|
Originally published In Press as doi:10.1074/jbc.M104580200 on June 14, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32136-32144, August 24, 2001
Gln3p Nuclear Localization and Interaction with Ure2p in
Saccharomyces cerevisiae*
Ajit A.
Kulkarni,
Ashraf T.
Abul-Hamd,
Rajendra
Rai,
Hassan
El
Berry, and
Terrance G.
Cooper
From the Department of Molecular Sciences, University of Tennessee,
Memphis, Tennessee 38163
Received for publication, May 18, 2001, and in revised form, June 6, 2001
 |
ABSTRACT |
Gln3p is one of two well characterized GATA
family transcriptional activation factors whose function is regulated
by the nitrogen supply of the cell. When nitrogen is limiting, Gln3p
and Gat1p are concentrated in the nucleus where they bind GATA
sequences upstream of nitrogen catabolite repression (NCR)-sensitive
genes and activate their transcription. Conversely, in excess nitrogen, these GATA sequences are unoccupied by Gln3p and Gat1p because these
transcription activators are excluded from the nucleus. Ure2p binds to
Gln3p and Gat1p and is required for NCR-sensitive transcription to be
repressed and for nuclear exclusion of these transcription factors.
Here we show the following. (i) Gln3p residues 344-365 are required
for nuclear localization. (ii) Replacing Ser-344, Ser-347, and Ser-355
with alanines has minimal effects on GFP-Gln3p localization. However,
replacing Gln3p Ser-344, Ser-347, and Ser-355 with aspartates results
in significant loss of its ability to be concentrated in the nucleus.
(iii) N and C termini of the Gln3p region required for it to complex
with Ure2p and be excluded from the nucleus are between residues 1-103
and 301-365, respectively. (iv) N and C termini of the Ure2p region
required for it to interact with Gln3p are situated between residues
101-151 and 330-346, respectively. (v) Loss of Ure2p residues
participating in either dimer or prion formation diminishes its ability
to carry out NCR-sensitive regulation of Gln3p activity.
 |
INTRODUCTION |
Saccharomyces cerevisiae is increasingly used as a
model to identify the functions of mammalian proteins as well as how
their production and activities are regulated and integrated. One of the gene families shared by S. cerevisiae and higher
eukaryotes is the GATA family of DNA-binding proteins. In animal cells,
GATA family proteins were originally shown to be responsible for
regulating globin gene expression (1). However, they are now known to regulate a diverse set of developmental functions (2, 3). In yeast, the
GATA family proteins Gln3p, Gat1p/Nil1p, Dal80p, Deh1p/Gzf3p have been
studied as the main regulators of nitrogen catabolic gene expression
(4-6), and recently their regulatory functions also been shown to be
far more diverse (7, 8). Gln3p and Gat1p are transcriptional
activators, whereas Dal80p and Deh1p repress transcription by competing
with these activators for binding to their target GATA sequences (4-6,
9-11).
Gln3p and Gat1p function is also dramatically regulated by the nitrogen
supply of the cell. When nitrogen is limiting, Gln3p and Gat1p are
concentrated in the nucleus, bind to the GATA sequences of their target
promoters, and activate transcription (8, 9, 12-15). On the other
hand, when nitrogen is in excess, Gln3p and Gat1p are excluded from the
nucleus, and nitrogen catabolite repression (NCR)1-sensitive gene
expression is repressed. Nuclear exclusion of Gln3p and Gat1p requires
Ure2p, the first NCR regulator identified (16, 17) and recently much
studied as a prion precursor (18-27). Nuclear exclusion also
correlates with hyperphosphorylation of Gln3p (8, 12-14), a process
that requires the phosphatidylinositol kinase-3 homologous Tor1/2p, and
is inhibited by the immunosuppressive, antifungal, antineoplastic drug
rapamycin (8, 12-14). The mechanistic details of the signal
transduction pathway associated with Gln3p and Gat1p controls, however,
are not fully understood. Some investigators (12) report Sit4p
phosphatase is required for dephosphorylation of Gln3p, its nuclear
entry, and NCR-sensitive gene expression, whereas others (8, 14) cannot
demonstrate Sit4p participation in Gln3p phosphorylation, localization,
and control. Similarly, Cardenas et al. (14) and Hardwick
et al. (8) find Ure2p to be phosphorylated, whereas Beck and
Hall do not (12). Although all in the field agree that Ure2p complexes
with Gln3p and Gat1p, the cause-effect relationships of Gln3p
phosphorylation, Ure2p-Gln3p complex formation, and the preeminent
determinant of Gln3p nuclear exclusion remain to be established.
Establishing the cause-effect relationships associated with Ure2p
control of Gln3p and Gat1p localization require a more detailed understanding of these proteins. Ure2p structure has been studied in
detail (26-28). The N-terminal asparagine-rich prion domain (amino
acids 1-65) is primarily, although not exclusively, required for prion
formation, whereas the C-terminal region (amino acids 66-354)
complements a ure2 null mutation for growth requiring ureidosuccinate uptake by an NCR-sensitive permease (19). For Gln3p,
three functional regions have been identified as follows: a
C2X17C2 zinc finger
motif (residues 306-330) that binds to GATA sequences (29), a
predicted -helical motif that mediates transcriptional activation
(residues 126-138) (30), and a large C-terminal region (residues
510-720) that associates with Tor1p (13).
Our purpose here is to identify sequences required: (i) for
nuclear-import of Gln3p, i.e. the nuclear localization
signal (NLS); (ii) for Gln3p to interact with Ure2p; and (iii) for
Ure2p to interact with Gln3p.
 |
EXPERIMENTAL PROCEDURES |
Strains and Growth Conditions--
The strains we used are
listed in Table I. Cultures were grown
overnight in YNB medium (0.17% YNB, with casamino acids, 0.5% ammonia, and 2% raffinose (GYC86) or glucose (TCY57)) to
A600 = 0.25-0.8 for microscopy. Auxotrophic
requirements were supplemented as necessary. Transformants of GYC86
were induced by adding galactose (final concentration, 4%).
Transformants of TCY57 were induced by transferring washed cells to YNB
galactose (4%), ammonia (0.5%) medium. Cultures were induced for 3 or
more hours. For -galactosidase assays YNB (0.17% YNB without
casamino acids, 2% glucose, and 0.1% appropriate nitrogen source)
medium was used.
Plasmid Constructions--
DNA cloning was performed using
standard methods (31). Oligonucleotides used in this work are listed in
the Table II. GFP-Gln3p deletion inserts
were cloned into the NdeI and HindIII sites of vector pNVS2. PCRs were performed using pRR312 (32), containing the
full-length Gln3p coding sequence with an internal NdeI site destroyed, as template. LexA-Ure2p inserts were cloned finally into the
sites of vector pEG202. Inserts were generated by standard PCR, using
pRD17 as a template (31), and cloning techniques. All constructs were
verified by DNA sequence analyses.
Fluorescence Microscopy--
Samples were prepared for
fluorescence microscopy as described earlier (9, 15, 33). Images were
irradiated with a combination of white and/or epi-fluorescent light,
viewed using the 63× objective of a Zeiss Axiophot microscope equipped
with a GFP filter set and collected with a Zeiss Axiocam digital camera
using AxioVision 2.0.5.3 software. Photographs were imported into
Photoshop 4.0.
-Galactosidase Assay--
Transformants were prepared and
assayed, including numbers of independent transformants assayed and
variation in observed results, as described (34).
Northern Blot Analysis--
Total RNA was prepared (11), and
hybridization reactions were performed as described (11). Hybridization
probes were generated using PCR products (7).
 |
RESULTS |
Gln3p Sequence Required for Nuclear
Localization--
Intracellular localization is the preeminent control
of Gln3p activity. To identify the Gln3p NLS, we constructed GFP-Gln3 C-terminal truncation proteins (Fig. 1,
upper portion). To ensure GFP-Gln3p retained normal
function, a gln3 was transformed with GFP-GLN3
pRR482. Complementation of the gln3 , measured as the ability to support DAL5 expression, was efficient even when
Gln3p was expressed at very low levels (Fig.
2, lane A). A minor species migrates just ahead of the DAL5 transcript. We don't know
its identity for sure, but its presence in both lanes eliminates the possibility that it is DAL5 mRNA because DAL5
expression does not occur in a gln3 (35) (Fig. 2,
lane B).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Gln3p truncations used in this work. 5'
and 3' gln3 deletions generated by PCR-based cloning in the
vector pNVS2. Bars indicate Gln3p residues remaining.
|
|

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 2.
Complementation of a gln3
by EGFP-GLN3. Cultures of strain RR912
(gln3 ), transformed with either vector pNVS2 or GFP-GLN3
pRR482, were grown in minimal glucose/proline medium. Total RNA from
these cultures was prepared and resolved in a Northern blot. A
full-length DAL5 gene was used as probe.
|
|
GFP-Gln3p truncation plasmids were transformed into wild type strain
GYC86, and their intracellular distribution was evaluated using
epifluorescence microscopy. GFP-Gln3 truncation proteins containing 365 or more N-terminal amino acids were concentrated in the nucleus (Fig.
3, left two columns). The
transformants did not, however, behave identically. Greater cytoplasmic
localization occurred with truncations GFP-Gln3p-(1-710) (pKA21) and
GFP-Gln3p-(1-680) (pKA24) than with GFP-Gln3p-(1-542) (pKA17) and
GFP-Gln3p-(1-487) (pKA42). The extent of cytoplasmic localization
increased again with GFP-Gln3p-(1-365) (pKA14) even though nuclear
concentration of GFP-Gln3p was clearly visible in all of the
transformants just mentioned. Nuclear concentration of GFP-Gln3p was
lost when residues between 301 (pKA10) and 365 (pKA14) were removed
(Fig. 3, left two columns). In fact, fluorescent material
can clearly be seen to be excluded from nuclei in cells where DNA is
situated in the neck between mother and daughter (Fig. 3, left
two columns, pKA10 arrows). These data argue the NLS C
terminus is between Gln3p residues 301 and 365. A similar approach
localized the N terminus of the Gln3p NLS (Fig. 1, lower
portion). Fluorescent material was largely nuclear in Gln3p
N-terminal truncations to residues 102 (pKA26), 186 (pKA27), 255 (pKA30), 296 (pKA34), and 343 (pKA36) (Fig.
4, left two columns). However,
truncation to amino acid 383 (pKA38) resulted in loss of nuclear
localization (Fig. 4, left two columns), localizing the N
terminus of the Gln3p NLS between residues 344 and 384.

View larger version (97K):
[in this window]
[in a new window]
|
Fig. 3.
Intracellular localization
of C-terminally truncated EGFP-Gln3 proteins.
GAL1,10-EGFP-GLN3 deletion plasmids (Fig. 1) were
transformed into WT GCY86 (left two columns of images) and
TCY57 (right two columns of images), which expresses
GAL1,10-URE2 at high levels. Transformants were viewed as described
under "Experimental Procedures."
|
|

View larger version (88K):
[in this window]
[in a new window]
|
Fig. 4.
Intracellular localization of N-terminally
truncated EGFP-Gln3 proteins. GAL1,10-EGFP-GLN3
deletion plasmids (Fig. 1) were transformed into WT GCY86 (left
two columns of images) and TCY57 (right two columns of
images), which expresses GAL1,10-URE2 at high levels. Transformants
were assayed as in Fig. 3.
|
|
Serine Residues in the NLS Are Not Absolutely Required for Nuclear
Localization--
The most likely NLS candidate in Gln3p region
301-384 is 343LSLKSDVIKKRISKKRAK360
which possesses significant similarity to other documented NLSs (36,
37). To establish whether this region was responsible for Gln3p nuclear
localization, we assayed a peptide (344-493, pKA36) in which basic
residues Lys-352, Arg-353, Lys-357, and Arg-358 were changed to
glutamate (pKA53). Fluorescent material concentrates in the nuclei of
wild type (pKA36) transformants, whereas it is cytoplasmic with mutant
pKA53 (Fig. 5).

View larger version (88K):
[in this window]
[in a new window]
|
Fig. 5.
Intracellular localization of EGFP-Gln3p
amino acid substitution mutant proteins. Upper four
rows of images: mutant GFP-gln3 plasmids were generated
and assayed as described under "Experimental Procedures."
Bottom image, EGFP-Gln3p fluorescence showing distinct foci
(arrows) similar to those observed with EGFP-Dal80p and
EGFP-Dal82p (45).
|
|
Work in several well studied nuclear transport systems suggests NLS
function can be regulated by phosphorylation (38-42). Since increased
Gln3p phosphorylation correlates with its nuclear exclusion, and
Gln3p-(344-365) contains a potential PKA-modification site, we first
determined whether Ser-344, Ser-347, and Ser-355 were themselves
required for nuclear localization by changing them to alanine (pKA52).
Nuclear localization of Gln3pS344A,S347A,S355A is
diminished minimally if at all (Fig. 5). If, on the other hand, these
serines are changed to negatively charged aspartates (pKA56), nuclear
localization is barely detectable (Fig. 5).
Gln3p Sequences Required for Interaction with Ure2p--
It is
well established that Gln3p/Gat1p and Ure2p form a complex in
vivo and in vitro (8, 9, 12-15). In addition,
overproduction of Ure2p results in loss of NCR-sensitive gene
expression, nuclear exclusion of GFP-Gln3p and GFP-Gat1p, with the
concomitant formation of highly punctate fluorescent foci identical to
those seen with GFP-Ure2p (9, 15, 22). These observations provide a
useful assay with which to identify Gln3p regions required for
interaction with Ure2p. We transformed C-terminal GFP-Gln3p deletion
plasmids described in the left two columns of Fig. 3 into
GAL1,10-URE2 strain TCY57 (9, 15). In contrast to data
obtained with the wild type strain, none of the truncated GFP-Gln3
proteins were concentrated in the nucleus; all localized to the
cytoplasm (Fig. 3, right two columns). In fact, GFP-Gln3p
was clearly excluded from many nuclei situated in the neck between
mother and daughter cells (Fig. 3, right two columns,
arrows). Furthermore, punctate foci similar to those previously
seen with GFP-Ure2p or GFP-Gln3p in the presence of high
URE2 expression (9, 15, 22) are clearly evident in many
micrographs (Fig. 3, right two columns), arguing that
sequences N-terminal to residue 301 are sufficient for Gln3p-Ure2p
interaction and GFP-Gln3p exclusion from the nucleus.
To localize further the Ure2p interaction site of Gln3p, we transformed
TCY57 with the N-terminal Gln3p deletion plasmids described in the
left two columns of Fig. 4 (Fig. 4, right two columns). GFP-Gln3p was nuclear in all cases except pKA38 which lacked the NLS. Therefore, N terminus of the Gln3p region required for
its interaction with Ure2p is between amino acids 1 and 103 and the C
terminus is N-terminal to 301.
Two-hybrid Assays with Ure2p as Bait--
To identify the Ure2p
residues required for interaction with Gln3p, we set-up a two-hybrid
assay (Fig. 6A) with
NLS-lexA-URE2 pAA15,
lexAoperator-lacZ pHS18-34, and a
GLN3-B42 plasmid (33, 44) as bait, reporter, and prey,
respectively. To our initial surprise, transformants of wild type
cells, containing only the bait and reporter plasmids (pAA15 plus
pHS18-34) produce high level -galactosidase (Fig.
7). This result is striking, because it
occurred in the absence of a "prey" plasmid. In a two-hybrid assay,
the prey plasmid insert normally encodes a protein, which activates transcription after being recruited to the promoter of a
reporter gene via its interaction with the "bait" protein bound to
multiple lexAoperator or Gal4p-binding sites
upstream of that reporter gene; the reporter gene promoter is devoid of upstream activation sequence (UAS) elements (44) (Fig.
6A). pAA15 and pHS18-34 are both required for the
-galactosidase production (Fig. 7). Additional standard controls
were performed to validate the surprising result, and the expected
results were observed (data not shown). These data, and the fact that
an SV40 NLS is fused to lexA sequences of bait vector
pEG202, into which URE2 was cloned, argue that Ure2p is
nuclear, binds to lexAoperator sites in the
lacZ promoter, and successfully recruits a native, endogenous molecule capable of supporting transcriptional activation to
the lacZ reporter gene promoter (Fig. 6B). This
bait-transcriptional activator complex then mediates lacZ
transcription. Upon further characterization, we found the
LexA-Ure2p-dependent lacZ expression to be
NCR-sensitive (Fig. 7). Note, however, that transcription with
glutamine as nitrogen source is a bit higher than normally occurs if a
typical NCR-sensitive gene, e.g. DAL5, had been
assayed (11).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Two-hybrid assay used to identify the regions
of Ure2p required for its interaction with Gln3p. A,
normal two-hybrid assay components showing the assembled complex
required for lacZ reporter gene expression. Here the
putative Ure2p-interacting protein is fused to the transcriptional
activation domain of B-42. The fusion protein is encoded by the insert
of the prey plasmid. B, two-hybrid assay with native,
endogenous Gln3p serving the role of the prey protein. In this
instance, no prey plasmid is required because Gln3p is providing the
trans-activation function, and no fusion to an activation domain is
required because Gln3p itself possesses a strong activation domain
(Gln3p-(126-138)). Full-length
NLSSV40-lexA-URE2 as well as
NLSSV40-lexA-ure2 deletion plasmids were used as
baits for the experiment in Fig. 7.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of gln3 and
ure2 deletion on LexA-Ure2p-mediated
-galactosidase production. Growth and assay
procedures are described under "Experimental Procedures."
|
|
A priori, the most likely candidate of an activator to
mediate NCR-sensitive transcription with LexA-Ure2p as bait is Gln3p, which predicts LexA-Ure2p-dependent -galactosidase
production should be Gln3p-dependent and Ure2p-regulated.
As shown in Fig. 7, the predicted results are observed experimentally.
It should be emphasized that native Ure2p encoded on the chromosome is
regulating LexA-Ure2p-mediated transcription (Fig. 6B). This
conclusion derives from the facts that (i) high levels of LexA-Ure2p
are present in both wild type and ure2 transformants
(LexA-URE2 expression is driven by the ADH promoter and the
gene is carried on a 2-µ-based plasmid), and (ii) deletion of
the resident, native URE2 gene exhibits a strong phenotype
that is not complemented by LexA-Ure2p. Therefore, two reactions occur
in which Gln3p complexes with Ure2p as follows: one in the cytoplasm
between endogenous, native Ure2p and Gln3p, which imparts NCR-sensitive
regulation; and the second in the nucleus between Gln3p and
heterologous NLS-LexA-Ure2p, which accounts for transcriptional
activation. The values observed with proline as nitrogen source reflect
binding between LexA-Ure2p and Gln3p, since Gln3p is minimally
influenced by Ure2p and has full access to the nucleus under this condition.
To identify Ure2p residues required for -galactosidase production
mediated by LexA-Ure2p, C- and N-terminal Ure2p truncations were
constructed. C-terminal truncation of only eight amino acids diminishes
lacZ expression by half (Fig.
8, pAA15 and
pAA107). Loss of another 16 amino acids completely
eliminates -galactosidase production (pAA113). The N-terminal 101 Ure2p residues are not required for -galactosidase production with
proline as nitrogen source (Fig. 8, pAA110 and
pAA114). Further N-terminal truncation, however, eliminates
-galactosidase production (pAA115), placing the N terminus between
residues 101 and 151.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 8.
-Galactosidase production
supported by truncated Ure2 proteins fused to LexA. Experiments
were performed in wild type STYC32. YNB glucose medium was used with
0.1% proline (PRO) or glutamine (GLN) as
nitrogen source.
|
|
When the experiment was repeated with glutamine as nitrogen source,
several differences were observed. (i) Truncation of the C-terminal
eight amino acids of Ure2p didn't severely decrease reporter gene
expression with proline (Fig. 8, pAA107). (ii) N-terminal truncation of
66 and 101 amino acids resulted in 6.5- and 10.2-fold increases in
expression compared with 1.7- and 1.3-fold observed with proline. In
other words, truncating LexA-Ure2p resulted in measurable loss of NCR
sensitivity (Fig. 8, pAA15, pAA110, and pAA114).
It is pertinent that lacZ expression in proline medium is
influenced only by complex formation between Gln3p and LexA-Ure2p, whereas in glutamine medium, it is also influenced by complex formation
between Gln3p and native Ure2p. By this reasoning, the loss of
LexA-Ure2p residues 1-65 does not measurably affect its ability to
bind Gln3p and mediate transcription, but it does affect Ure2p-Gln3p
complex formation occurring in the cytoplasm and hence the ability of
native Ure2p to function properly when cells are provided with
glutamine as nitrogen source.
Finally, we constructed an internal deletion, which removed Ure2p amino
acids 224-229. Although this truncation is situated within the
LexA-Ure2p region required for lacZ expression, no deleterious effects are observed with proline as nitrogen source (Fig.
8). With glutamine, this truncation, like those encoded by pAA110 and
pAA114, mediates reporter gene expression that is partially resistant
to NCR (Fig. 8).
GFP-Gln3p Occasionally Exhibits Intranuclear Localization Similar
to That Seen with GFP-Dal82p--
Cells transformed with a
GFP-DAL80 plasmid exhibit fluorescent foci that co-localize
with 4,6-diamidino-2-phenylindole-positive material and follow DNA
movement through the cell cycle (45). High resolution confocal and
deconvolution microscopy delineate up to 16 distinct foci, which
correlates with the number of S. cerevisiae chromosomes
(45). DAL80 encodes a repressor protein, which binds to some
of the same GATA sequences as Gln3p (10, 32, 46-48). GFP-Dal82p
generates similar fluorescent foci, although they are considerably less
well defined than seen with GFP-Dal80p (33, 45, 49, 50). Since we were
viewing hundreds of fields of cells transformed with
GFP-GLN3 plasmids, we queried whether or not images similar
to those mentioned above also occurred with GFP-Gln3p. Intra-nuclear
distribution of GFP-Gln3p fluorescent material similar to that seen
with GFP-Dal82p were occasionally seen (compare Fig. 5, bottom
image, arrows, with Fig. 2, row 4, of Ref. 45).
 |
DISCUSSION |
Present and past data show most Gln3p component functions localize
to the N-terminal half of the molecule as follows: transcriptional activation, a predicted -helical structure at residues 126-138 (30); Ure2p-interacting region at residues 1-301 (right two columns, Figs. 3 and 4); GATA binding, a C-4 zinc finger at
residues 306-330 (29, 32, 51); nuclear localization at residues
344-365 (left two columns, Figs. 3-5), potentially nuclear
export signals at residues 64-73 and/or 336-345, and Tor1p-binding at
residues 510-720 (13) (Fig. 9).
Although Gln3p residues 344-365 are necessary and sufficient for
nuclear localization of Gln3p, residues 542-680 also influence this
process. This conclusion derives from consistently observing more
fluorescent material in the cytoplasm of transformants containing GFP-Gln3p-(1-730, 1-710, and 1-680) than with GFP-Gln3p-(1-542) (Fig. 3). Eliminated from consideration as potential NLS sites are
Gln3p basic regions 390-394, 477-482, and 264-270. This conclusion is based on the cytoplasmic localizations of Gln3p-(344-493) (pKA56), containing residues 390-394 and 477-482 (Fig. 5), and Gln3p-(1-301) (pKA10), containing residues 264-270.
Two related assays localized the Ure2p-interacting region of Gln3p to
residues 1-301. The nuclear exclusion assay in cells overexpressing
URE2 localized the interacting region to residues 1-365. Further
resolution could not be achieved because the assay requires functional
integrity of NLS residues 344-365. Using the second assay,
i.e. GFP-Gln3p generated punctate fluorescence when Ure2p is
overproduced, resolved the interacting region to Gln3p residues 1-301
(Fig. 3, pKA10, right two columns). Data from pKA26 (Fig. 4,
right two columns) might be suggested to localize the N
terminus of the Ure2p-interacting region to residues 1 and 102. This
interpretation isn't justified, however, because Gln3p contains two
nuclear export signal (NES)-homologous sequences, residues 336-345 and
64-73. If residues 64-73 were to serve as the unique Gln3p NES, their
removal might result in nuclear localization of GFP-Gln3p due to lack
of a mechanism for the protein to exit from the nuclear compartment.
If, alternatively, residues 336-345 uniquely serve this function, the
N terminus of the Ure2p-interacting region is somewhere between amino
acids 1 and 102.
The Gln3p topology diagrammed in Fig. 9 influences interpretation of
data addressing how Ure2p regulates Gln3p. For example, one mechanism
envisions Ure2p binds directly to the NLS thereby sterically preventing
it from functioning. Although elements of this idea remain tenable,
such steric hindrance would have to occur indirectly as a result of
Ure2p-binding N-terminal to the NLS. In this regard, it is interesting
to note that the Gln3p transcriptional activation and DNA-binding
domains are situated between the proposed Ure2p interaction site and
the NLS. Also, because of their locations, it is reasonable to suggest
the Gln3p DNA binding and transcriptional activation regions may point
away from those needed for Ure2p interaction. At least for the DNA transcriptional activation domain, this suggestion is supported by the
observation that Gln3p is able to mediate transcriptional activation
when bound to LexA-Ure2p (Fig. 7).
The LexA-Ure2p experiment generated further insight into the
functioning of Ure2p, Gln3p, and their interaction. LexA-Ure2p-mediated transcription argues that Ure2p is cytoplasmic, not because it is
tethered but because it simply lacks a functional NLS or,
alternatively, that NLSSV40LexA fused to Ure2p inactivates
the tethering mechanism. We favor the first explanation and feel that
the inability of LexA-Ure2p to complement ure2 mutations
could be one outcome of it.
NLSSV40 fused to Ure2p can mediate nuclear uptake,
whereas the NLS provided by Gln3p, when it forms the cytoplasmic
Ure2pnative-Gln3pnative complex, is
insufficient to permit nuclear entry. One explanation of the data would
posit that single molecules, but not complexes consisting of multiple
molecules, can be transported into the nucleus. Alternatively, this
experimental result may support the question of whether
NLSGln3p phosphorylation or Ure2p binding is primarily
responsible for Gln3p exclusion from the nucleus. Gln3pS344A,S347A,S355A (pKA52) demonstrates that serine
residues per se at these positions are not required for NLS
function. The Gln3p-(344-493)S344D,S347D,S355D variant
most closely mimics the effects of phosphorylating these serines,
because they confer a negative charge to this region of Gln3p. In
addition, these residues encompass a potential PKA modification site,
KRIS355. Although these mutant data are consistent
with the contention that NLS phosphorylation plays a regulatory role,
they certainly do not prove it. On the other hand, the in
vivo demonstration that URE2 overexpression excludes
Gln3p and Gat1p from the nucleus and represses NCR-sensitive
transcription in proline-grown cells indicates that high level NCR can
be exerted in the absence of the cellular signal generated by excess
nitrogen, because proline-grown cells do not contain it. Therefore, by
the current models in the literature, this NCR would be occurring in
under conditions of hypo-phosphorylation (9, 15) and hence argues in
favor of Gln3p-Ure2p complex formation being the more important
regulatory determinant. That conclusion, however, does not exclude a
role for phosphorylation outside of its influence on Gln3p-Ure2p
complex formation. It is quite conceivable that NCR-sensitive
GAT1 and GAP1 expression that occurs in a
gln3 ure2 mutant derives from phosphorylating Gat1p in
response to nitrogen excess (52). Similarly by this reasoning,
NCR-sensitive DAL5 expression that occurs in a
gat1 ure2 mutant can be argued to derive from
phosphorylating Gln3p when glutamine is supplied as sole nitrogen
source (52).
The LexA-Ure2p truncation experiments offer additional insights into
Ure2p itself. Genetic studies led Wickner's laboratory to conclude the
Ure2p prion-forming domain was N-terminal (amino acids 1-65), with the
C terminus being sufficient for NCR-sensitive transcriptional
regulation imposed upon Gln3p (18, 19). Our LexA-Ure2p data with
proline as nitrogen source (Fig. 8) confirm their view, demonstrating
the N and C termini of the Ure2p region needed for Gln3p binding to be
between residues 101-151 and 330-346, respectively. Higher resolution
experiments demonstrated that although prion formation was
predominantly N-terminal, C-terminal portions of Ure2p also
participated (24). Data presented here similarly argue that whereas
NCR-sensitive transcriptional regulation is predominantly a Ure2p
C-terminal function, the first 65 amino acids participate in this
control as well (Fig. 8).
The LexA-Ure2p truncation experiments leave an apparent paradox.
Full-length LexA-Ure2p mediates NCR-sensitive lacZ, arguing the fusion protein plays no role in the cytoplasm. However, removing either the first 65 Ure2p residues or those between 223 and 230 diminishes NCR-sensitive regulation. How could this be? The explanation that makes most sense to us posits the occurrence of negative complementation. Although Ure2p is a dimer in solution (26, 27),
whether this is required for its regulatory role isn't known. Our data
are most easily explained if it is. Both regions of Ure2p, the
truncation of which are deleterious to NCR-sensitive regulation, are
associated with Ure2p-Ure2p interaction, the prion-forming domain
(residues 1-65) (18), and the 5 helix which forms the Ure2p
dimerization interface (26, 27). Therefore, Ure2p heterodimers consisting of Ure2pnative and LexA-Ure2p-(66-354) or
LexA-Ure2p-(224-229 ) would be expected to form less stably than the
Ure2pnative-Ure2pnative homodimer, which
contains both interacting regions. Note that pAA111 in which the
dimerization interface is directly damaged also possesses the stronger
phenotype, i.e. one-third of the NCR sensitivity is lost.
But why wasn't an even stronger phenotype in glutamine medium observed
since there is far more lexA-ure2 than URE2
expression in the cell? Although this is true, the SV40 NLS fused to
LexA-Ure2 mutant protein would result in its nuclear concentration,
resulting in less mutant LexA-Ure2p being available in the cytoplasm to
dimerize with Ure2pnative molecules. Analogously, it is
appropriate to question that if
LexA-Ure2p-(66-354)-Ure2pnative forms a less stable
complex with Gln3p than
Ure2pnative-Ure2pnative, why isn't this
reflected in similarly weaker
LexA-Ure2p-(66-354)-LexA-Ure2p-(66-354)-Gln3p complex being formed at
the site of transcription, hence lowering lacZ expression
supported by pAA15 compared with pAA110 in proline medium. Two
possibilities come to mind. (i) The interaction of the
LexA-Ure2p-LexA-Ure2p-Gln3p complex with components of the core
transcription complex contribute to stabilization such as is seen when
the presence of Dal82p suppresses mutations in
uasNTR. (ii) Ure2p in its dimer form is not required
for binding to Gln3p but is required for Ure2p to prevent Gln3p from
gaining entry into the nucleus. Crystallographic data for Ure2p
complexed with Gln3p will, no doubt, greatly contribute to a more
complete understanding of these in vivo data.
The LexA-Ure2p is not the first protein shown to support
Gln3p-dependent reporter gene transcription and/or complex
with Gln3p. (i) LexA-Dal82p mediates Gln3p-dependent
lacZ expression under experimental conditions similar to
those reported here (33, 44). Furthermore, there is independent genetic
evidence supporting the contention that Dal82p and Gln3p interact with
one another, i.e. mutations in the UASNTR,
Gln3p-binding site are suppressed by placing a functioning
Dal82p-binding site adjacent to the mutated uasNTR (50). This suppression is
Dal82p-dependent. (ii) The coiled-coil domain of Dal82p
interacts with Dal81p (44). (iii) The Gln3p, Dal80p, and Deh1p/Gzf3p
zinc finger motifs all interact with one another in a two-hybrid
reaction but not with the zinc finger motif of Put3p (47). From this
perspective, we propose the following interpretation of the recent
report that a Tor1p bait plasmid, fused to a Galp-DNA-binding domain,
yields positive interactions with prey plasmids in which the Gal4p
activation domain was fused to Gln3p-(510-720), Ure2p, Dal82p, Dal81p,
Dal80p, Gat1p, and Deh1p/Gzf3p (13). In our view, these data derive from Tor1p interacting with Gln3p and/or Gat1p and that the remaining interactions occur through the intermediacy of these transcriptional activators. This interpretation also points to the possibility that
Gln3p, Gat1p, Dal81p, Dal82p, and perhaps the transcriptional repressors, Dal80p and Deh1p/Gzf3p, are situated in a larger
multitranscription factor complex as suggested earlier (44, 50).
 |
ACKNOWLEDGEMENTS |
We thank Tim Higgins for preparing
the artwork and the University of Tennessee Yeast Group for suggested
improvements to the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM-35642.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 901-448-6179;
Fax: 901-448-8462; E-mail: tcooper@utmem.edu.
Published, JBC Papers in Press, June 14, 2001, DOI 10.1074/jbc.M104580200
 |
ABBREVIATIONS |
The abbreviations used are:
NCR, nitrogen
catabolite repression;
GFP, green fluorescent protein;
NLS, nuclear
localization signal;
PCR, polymerase chain reaction.
 |
REFERENCES |
| 1.
|
Weiss, M. J.,
and Orkin, S. H.
(1995)
Exp. Hematol.
23,
99-107
|
| 2.
|
Kelley, C.,
Blumberg, H.,
Zon, L. I.,
and Evans, T.
(1993)
Development
118,
817-827
|
| 3.
|
Laverriere, A. C.,
MacNeill, C.,
Mueller, C.,
Poelmann, R. E.,
Burch, J. B.,
and Evans, T.
(1994)
J. Biol. Chem.
269,
23177-23184
|
| 4.
|
Cooper, T. G.
(1996)
in
The Mycota III
(Marzluf, G.
, and Bambrl, R., eds)
, pp. 139-169, Springer-Verlag, Berlin
|
| 5.
|
ter Schure, E. G.,
van Riel, N. A.,
and Verrips, C. T.
(2000)
FEMS Microbiol. Rev.
24,
67-83
|
| 6.
|
Hoffman-Bang, J.
(1999)
Mol. Biotechnol.
12,
35-73
|
| 7.
|
Cox, K. H.,
Pinchak, A. B.,
and Cooper, T. G.
(1999)
Yeast
15,
703-713
|
| 8.
|
Hardwick, J. S.,
Kuruvilla, F. G.,
Tong, J. K.,
Shamji, A. F.,
and Schreiber, S. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14866-14870
|
| 9.
|
Cunningham, T. S.,
Andhare, R.,
and Cooper, T. G.
(2000)
J. Biol. Chem.
275,
14408-14414
|
| 10.
|
Cunningham, T.,
Dorrington, R. A.,
and Cooper, T. G.
(1994)
J. Bacteriol.
176,
4718-4725
|
| 11.
|
Daugherty, J. R.,
Rai, R.,
El Berry, H. M.,
and Cooper, T. G.
(1993)
J. Bacteriol.
175,
64-73
|
| 12.
|
Beck, T.,
and Hall, M. N.
(1999)
Nature
402,
689-692
|
| 13.
|
Bertram, P. G.,
Choi, J. H.,
Carvalho, J.,
Ai, W.,
Zeng, C.,
Chan, T. F.,
and Zheng, X. F.
(2000)
J. Biol. Chem.
275,
35727-35733
|
| 14.
|
Cardenas, M. E.,
Cutler, N. S.,
Lorenz, M. C.,
Di Como, C. J.,
and Heitman, J.
(1999)
Genes Dev.
13,
3271-3279
|
| 15.
|
Cox, K. H.,
Rai, R.,
Distler, M.,
Daugherty, J. R.,
Coffman, J. A.,
and Cooper, T. G.
(2000)
J. Biol. Chem.
275,
17611-17618
|
| 16.
|
Drillen, R.,
and Lacroute, F.
(1972)
J. Bacteriol.
109,
203-208
|
| 17.
|
Drillen, R.,
Aigle, M.,
and Lacroute, F.
(1973)
Biochem. Biophys. Res. Commun.
53,
367-372
|
| 18.
|
Wickner, R. B.
(1994)
Science
264,
566-569
|
| 19.
|
Masison, D. C.,
and Wickner, R. B.
(1995)
Science
270,
93-95
|
| 20.
|
Masison, D. C.,
Maddelein, M.-L.,
and Wickner, R. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12503-12508
|
| 21.
| Deleted in proof
|
| 22.
|
Edskes, H. K.,
Gray, V. T.,
and Wickner, R. B.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1498-1503
|
| 23.
|
Fernandez-Bellot, E.,
Guillemet, E.,
Baudin-Baillieu, A.,
Gaumer, S.,
Komar, A. A.,
and Cullin, C.
(1999)
Biochem. J.
338,
403-407
|
| 24.
|
Maddelein, M.-L.,
and Wickner, R. B.
(1999)
Mol. Cell. Biol.
19,
4516-4524
|
| 25.
|
Wickner, R. B.,
Taylor, K. L.,
Edskes, H. K.,
Maddelein, M. L.,
Moriyama, H.,
and Roberts, B. T.
(2000)
J. Struct. Biol.
130,
310-322
|
| 26.
|
Umland, T. C.,
Taylor, K. L.,
Rhee, S.,
Wickner, R. B.,
and Davies, D. R.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
1459-1464
|
| 27.
|
Thual, C.,
Bousset, L.,
Komar, A. A.,
Walter, S.,
Buchner, J.,
Cullin, C.,
and Melki, R.
(2001)
Biochemistry
40,
1764-1773
|
| 28.
|
Bousset, L.,
Belrhali, H.,
Janin, J.,
Melki, R.,
and Morera, S.
(2001)
Structure
9,
39-46
|
| 29.
|
Omichinski, J. G.,
Clore, G. M.,
Schaad, O.,
Felsenfeld, G.,
Trainor, C.,
Appella, E.,
Stahl, S. J.,
and Gronenborn, A. M.
(1993)
Science
261,
438-446
|
| 30.
|
Svetlov, V.,
and Cooper, T. G.
(1997)
J. Bacteriol.
179,
7644-7652
|
| 31.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 32.
|
Cunningham, T. S.,
Svetlov, V. V.,
Rai, R.,
Smart, W.,
and Cooper, T. G.
(1996)
J. Bacteriol.
178,
3470-3479
|
| 33.
|
Scott, S.,
Dorrington, R.,
Svetlov, V.,
Beeser, A. E.,
Distler, M.,
and Cooper, T. G.
(2000)
J. Biol. Chem.
275,
7198-7204
|
| 34.
|
Smart, W. C.,
Coffman, J. A.,
and Cooper, T. G.
(1996)
Mol. Cell. Biol.
16,
5876-5887
|
| 35.
|
Cooper, T. G.,
Ferguson, D.,
Rai, R.,
and Bysani, N.
(1990)
J. Bacteriol.
172,
1014-1018
|
| 36.
|
Cokol, M.,
Nair, R.,
and Rost, B.
(2000)
EMBO Rep.
1,
411-415
|
| 37.
|
Young, M. R.,
Suzuki, K.,
Yan, H.,
Gibson, S.,
and Tye, B. K.
(1997)
Genes Cells
2,
631-643
|
| 38.
|
Azuma, Y.,
Takio, K.,
Tabb, M. M.,
Vu, L.,
and Nomura, M.
(1997)
Biochimie (Paris)
79,
247-259
|
| 39.
|
Ferrigno, P.,
Posas, F.,
Koepp, D.,
Saito, H.,
and Silver, P. A.
(1998)
EMBO J.
17,
5606-5614
|
| 40.
|
Jans, D. A.,
and Hubner, S.
(1996)
Physiol. Rev.
76,
651-685
|
| 41.
|
Jans, D. A.,
Moll, T.,
Nasmyth, K.,
and Jans, P.
(1995)
J. Biol. Chem.
270,
17064-14067
|
| 42.
|
Moll, T.,
Tebb, G.,
Surana, U.,
Robitsch, H.,
and Nasmyth, K.
(1991)
Cell
66,
743-758
|
| 43.
|
Blinder, D.,
Coschigano, P. W.,
and Magasanik, B.
(1996)
J. Bacteriol.
178,
4734-4736
|
| 44.
|
Scott, S.,
Abul-Hamd, A. T.,
and Cooper, T. G.
(2000)
J. Biol. Chem.
275,
30886-30893
|
| 45.
|
Distler, M.,
Kulkarni, A.,
Rai, R.,
and Cooper, T. G.
(2001)
J. Bacteriol.
183,
4636-4642
|
| 46.
|
Cunningham, T. S.,
and Cooper, T. G.
(1993)
J. Bacteriol.
175,
5851-5861
|
| 47.
|
Svetlov, V. V.,
and Cooper, T. G.
(1998)
J. Bacteriol.
180,
5682-5688
|
| 48.
|
Chisholm, G.,
and Cooper, T. G.
(1982)
Mol. Cell. Biol.
2,
1088-1095
|
| 49.
|
Rai, R.,
Genbauffe, F. S.,
Sumrada, R. A.,
and Cooper, T. G.
(1989)
Mol. Cell. Biol.
9,
602-608
|
| 50.
|
van Vuuren, H. J. J.,
Daugherty, J. R.,
Rai, R.,
and Cooper, T. G.
(1991)
J. Bacteriol.
173,
7186-7195
|
| 51.
|
Minehart, P. L.,
and Magasanik, B.
(1991)
Mol. Cell. Biol.
11,
6216-6228
|
| 52.
|
Coffman, J. A.,
Rai, R.,
Cunningham, T.,
Svetlov, V.,
and Cooper, T. G.
(1996)
Mol. Cell. Biol.
16,
847-858
|
| 53.
|
Coffman, J. A.,
El Berry, H. M.,
and Cooper, T. G.
(1994)
J. Bacteriol.
176,
7476-7483
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Tate, I. Georis, A. Feller, E. Dubois, and T. G. Cooper
Rapamycin-induced Gln3 Dephosphorylation Is Insufficient for Nuclear Localization: Sit4 AND PP2A PHOSPHATASES ARE REGULATED AND FUNCTION DIFFERENTLY
J. Biol. Chem.,
January 23, 2009;
284(4):
2522 - 2534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Wong, M. J. Hynes, and M. A. Davis
Recent Advances in Nitrogen Regulation: a Comparison between Saccharomyces cerevisiae and Filamentous Fungi
Eukaryot. Cell,
June 1, 2008;
7(6):
917 - 925.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Puria, S. A. Zurita-Martinez, and M. E. Cardenas
From the Cover: Nuclear translocation of Gln3 in response to nutrient signals requires Golgi-to-endosome trafficking in Saccharomyces cerevisiae
PNAS,
May 20, 2008;
105(20):
7194 - 7199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Georis, J. J. Tate, T. G. Cooper, and E. Dubois
Tor Pathway Control of the Nitrogen-responsive DAL5 Gene Bifurcates at the Level of Gln3 and Gat1 Regulation in Saccharomyces cerevisiae
J. Biol. Chem.,
April 4, 2008;
283(14):
8919 - 8929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Luzzani, S. B. Cardillo, M. Bermudez Moretti, and S. Correa Garcia
New insights into the regulation of the Saccharomyces cerevisiae UGA4 gene: two parallel pathways participate in carbon-regulated transcription
Microbiology,
November 1, 2007;
153(11):
3677 - 3684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Shewmaker, L. Mull, T. Nakayashiki, D. C. Masison, and R. B. Wickner
Ure2p Function Is Enhanced by Its Prion Domain in Saccharomyces cerevisiae
Genetics,
July 1, 2007;
176(3):
1557 - 1565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Giannattasio, Z. Liu, J. Thornton, and R. A. Butow
Retrograde Response to Mitochondrial Dysfunction Is Separable from TOR1/2 Regulation of Retrograde Gene Expression
J. Biol. Chem.,
December 30, 2005;
280(52):
42528 - 42535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Hansen, Y. Gu, M. Li, M. Andrykovitch, D. S. Waugh, D. J. Jin, and X. Ji
Structural Basis for the Function of Stringent Starvation Protein A as a Transcription Factor
J. Biol. Chem.,
April 29, 2005;
280(17):
17380 - 17391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Boczko, T. G. Cooper, T. Gedeon, K. Mischaikow, D. G. Murdock, S. Pratap, and K. S. Wells
Structure theorems and the dynamics of nitrogen catabolite repression in yeast
PNAS,
April 19, 2005;
102(16):
5647 - 5652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Cox, J. J. Tate, and T. G. Cooper
Actin Cytoskeleton Is Required For Nuclear Accumulation of Gln3 in Response to Nitrogen Limitation but Not Rapamycin Treatment in Saccharomyces cerevisiae
J. Biol. Chem.,
April 30, 2004;
279(18):
19294 - 19301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Baxa, K. L. Taylor, J. S. Wall, M. N. Simon, N. Cheng, R. B. Wickner, and A. C. Steven
Architecture of Ure2p Prion Filaments: THE N-TERMINAL DOMAINS FORM A CENTRAL CORE FIBER
J. Biol. Chem.,
October 31, 2003;
278(44):
43717 - 43727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Carvalho and X. F. S. Zheng
Domains of Gln3p Interacting with Karyopherins, Ure2p, and the Target of Rapamycin Protein
J. Biol. Chem.,
May 2, 2003;
278(19):
16878 - 16886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Martin, M. C. Brandriss, G. Schneider, and A. T. Bakalinsky
Improved Anaerobic Use of Arginine by Saccharomyces cerevisiae
Appl. Envir. Microbiol.,
March 1, 2003;
69(3):
1623 - 1628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-C. Li
Genome-wide coexpression dynamics: Theory and application
PNAS,
December 24, 2002;
99(26):
16875 - 16880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Fraser, M. A. Davis, and M. J. Hynes
A Gene from Aspergillus nidulans with Similarity to URE2 of Saccharomyces cerevisiae Encodes a Glutathione S-Transferase Which Contributes to Heavy Metal and Xenobiotic Resistance
Appl. Envir. Microbiol.,
June 1, 2002;
68(6):
2802 - 2808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Baxa, V. Speransky, A. C. Steven, and R. B. Wickner
Inaugural Article: Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein
PNAS,
April 16, 2002;
99(8):
5253 - 5260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Bertram, J. H. Choi, J. Carvalho, T.-F. Chan, W. Ai, and X. F. S. Zheng
Convergence of TOR-Nitrogen and Snf1-Glucose Signaling Pathways onto Gln3
Mol. Cell. Biol.,
February 15, 2002;
22(4):
1246 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|